What many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.
FDA regulations under Food, Drug, and Cosmetic Act outline efficacy, safety requirements for animal pharmaceuticals.
Education and support inspire trust between patients and pharmacists.
Little progress has been made in developing treatments that can help to stop Ewing sarcomas from spreading or coming back.
Community pharmacists have a unique opportunity to counsel caregivers on liquid OTC children’s products.
Tapping techs as immunizers opens up greater visibility and new source of health care labor.
Treatment's approval marks exciting new development for patients with ES-SCLC to prevent CIM.
Pharmacists' expertise is crucial in educating patients about regulatory changes, helping them navigate alternative formulations, and providing insights into evidence-based choices.
There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
With gastrointestinal-based adverse effectss for rivastigmine and other cholinesterase inhibitors, a weight of <50 and <55 kg respectively leads to an increased risk for toxicities.
A pharmacist’s role in the ambulatory care setting has traditionally included a review of medications for potential drug-drug interactions and adverse events, medication reconciliation, and the provision of counseling services.
In hospital pharmacies, roughly 2% of pharmacy spend can be overcharge.
Children's books about the field of pharmacy are surprisingly scarce.
When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.
Infectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.
This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
New access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.
Part 1 of this 4-part series provides a general overview of the trends that are moving payers and pharmaceutical companies in this direction.
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.
Because of the likelihood that patients with melanoma will develop adverse effects on therapy, it is crucial for pharmacists to proactively educate patients and provide them with tools to help mitigate and manage these issues.
Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
These agents are likely to become the mainstay of cancer treatment in the very near future.
Experts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
Utilization of the RAPID3 tool can be a beneficial way for pharmacists to complete disease activity assessments without physically seeing the patient in a clinic setting.
CGM enhances diabetes management in pregnancy, improving outcomes.
Advanced analytics will continue to make health care more accessible and empower pharmacists with the ability to personalize treatments.
Although it is critical that we listen to every patient we treat, it's also important to listen to the needs of our bodies first, as this will allow us to better care for others.
The screenings should be conducted every other year, beginning at age 40 and continuing through age 74, according to the new recommendation.